The top prize of this MLB free-agent class is left-hander Tarik Skubal, a two-time Cy Young winner. Projections suggest he could command an 8- to 10-year contract exceeding $400 million, a figure that often triggers concerns about risk. However, a closer look at his performance, workload, injury history, and how elite pitchers have aged recently indicates such a deal might actually represent good value.
Track Record and Workload
Since returning from surgery in 2023, Skubal has been dominant across his age-26 to age-29 seasons. In 103 starts he owns a 50-20 record, a 2.47 ERA (169 ERA+), 0.92 WHIP, and 757 strikeouts in 626⅓ innings while walking just 109 batters (1.6 BB/9). His postseason resume is equally impressive: eight starts, 2.13 ERA, 0.79 WHIP, 70 strikeouts against nine unintentional walks in 50⅔ innings. Importantly, his career regular-season workload stands at only 925⅓ innings through age 29 — well below the 1,553⅔ innings Justin Verlander had logged by the same age, suggesting plenty of remaining durability.
Age and Injury History
Skubal turns 30 in 2027. His injury ledger includes Tommy John surgery in college, flexor tendon surgery in 2022, and an arthroscopic procedure using a Nanoscope in 2026. After the latest surgery he missed roughly six weeks, then returned to make 19 starts with a 2.73 ERA and 141 strikeouts in 115⅓ innings. Modern pitchers frequently recover from elbow procedures to perform at a high level, and Skubal’s quick return supports that trend.
Pitchers Aging Well in Recent Memory
History shows elite starters can remain effective deep into their 30s. Verlander won Cy Young awards at 36 and 39; Max Scherzer posted 5.3 WAR with a 2.29 ERA at 37; Chris Sale captured a Cy Young at 35 and excelled at 37; Zack Wheeler returned from thoracic outlet surgery at 36 to produce 6.1 WAR; Jacob deGrom logged a 2.97 ERA in 30 starts at 37; Sonny Gray went 18-5 with a 2.72 ERA at 36; and Zack Greinke remained strong at 35 and 38. An eight-year deal for Skubal would cover his age-30 through age-37 seasons, a window where comparable aces have thrived.
Recent Mega Deals for Pitchers
Large pitcher contracts have largely paid off. Gerrit Cole (9 years, $324M) has delivered a Cy Young, multiple top-four finishes, and 22.4 WAR despite Tommy John surgery. Max Fried (8 years, $218M) is 24-10 with a 2.83 ERA in two years. David Price (7 years, $217M) won a World Series and posted a 118 ERA+. CC Sabathia (9 years, $202M) accumulated 27.1 WAR and five 200-inning seasons. Max Scherzer (7 years, $191.4M) won two Cy Youngs, a World Series, and 41.8 WAR. Even the Stephen Strasburg deal (7 years, $245M) brought a title before injuries derailed it. The track record suggests long-term investments in top-tier arms often succeed.
Value Assessment
Using a common $8 million per WAR valuation, Skubal’s production was worth approximately $48.4 million in 2024, $53.7 million in 2025, and $41.7 million in 2026. Given his consistent excellence, low career innings, and the aging patterns of similar pitchers, a 10-year, $400 million contract could arguably be a bargain rather than a gamble.



